SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ttk Healthcare submits unaudited financial results

03 Nov 2023 Evaluate
Ttk Healthcare has informed that it enclosed the Unaudited Financial Results along with the Limited Review Report from the Statutory Auditors of the Company, for the Second Quarter and Half-Year ended 30th September, 2023, duly reviewed by the Audit Committee at their meeting held yesterday on 2nd November, 2023 and approved by the Board of Directors of the Company at their Meeting held today.

The above information is a part of company’s filings submitted to BSE.


TTK Healthcare Share Price

926.85 39.05 (4.40%)
21-Apr-2026 11:37 View Price Chart
Peers
Company Name CMP
Grasim Industries 2782.70
DCM Shriram 1195.00
3M India 31640.00
Hindustan Foods 488.05
Balmer Lawrie & Co 177.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×